#Chubby boa valenti full

His work has a strong translational component, asking if both classically and non-classically restricted T cells are associated with infection with M. This research has focused largely on CD8+ T cells, with a focus on both those antigens that are recognised, and the means by which they are presented. His research has centered on understanding the mechanisms by which the human immune system recognises the Mycobacterium tuberculosis (M.tb) infected cell. MD, PhD, Professor and Vice Chair for Research, Department of Medicine, Director OHSU Center for Global Child Health Research, Department of Pediatrics. The research goal is to improve understanding of the immunopathology of TB and HIV, using this information to aid in developing novel therapeutic approaches and diagnostic biomarkers. He is an HIV and TB immunologist focused on studying the immune response to these pathogens in affected tissues, and how this relates to what can be observed from the blood. Principal investigator Africa Health Research Institute (AHRI), Durban, South Africa Associate Professor, University of KwaZulu Natal, Durban, South Africa Wellcome Trust senior Fellow, department of infection and immunity, University College London, UK. He has been an author on over 150 manuscripts in the field of infectious diseases and has an extensive track record in infectious diseases research and practice covering clinical, laboratory and epidemiological aspects.

#Chubby boa valenti full

Full Professor and Chair of Tropical Medicine and Travel Medicine and Head, Center of Tropical Medicine and Travel Medicine, Amsterdam Medical Centre, University of Amsterdam in the Netherlands. Specialist in Internal Medicine, Infectious Diseases, Tropical Medicine. Her TB research includes examining new agents to prevent TB, TB prophylaxis and TB vaccine evaluation. Her research interests include HIV vaccine research, microbicide research and other biomedical and behavioural interventions, and she is an investigator in testing two HIV vaccine regimens in late stage clinical development. Her Research Unit is involved with clinical research, epidemiology and operational research, and is a treatment site for HIV infected adults and children. Executive Director Perinatal HIV Research Unit, Wits Health Consortium, University of Witwatersrand Associate Professor, Department of Paediatrics, University of Witwatersrand, South Africa HVTN Director of International Programmes HVTN Co-Principal Investigator Chair of the standing committee on Health, ASSAF. He is the past Chair of Immunology at UCT and holder of several NIH and European-based grants.

He has an active group within the IDM and is based at Stellenbosch University where he directs the Reproductive Immunology Research Consortium in Africa (RIRCA). He focuses on Immune ontogeny in HIV exposed infants, placental investigations and pre-term birth, and epithelial immunity in the foreskin. His research interests revolve around investigating immune regulation and dysregulation in the context of HIV infection or exposure. Professor Emeritus of Immunology, Division of Immunology, Department of Pathology, University of Cape Town Professor of Immunology in Molecular Biology and Human Genetics, Stellenbosch University, Cape Town Adjunct Professor, Department of Immunology, Duke University, North Carolina, USA Secretary-General, Federation of African Immunology Societies Vice-Chair, Education Committee of the IUIS Director of the Immunopaedia Foundation. His primary research interests are C-type lectin receptors and their role in homeostasis and immunity, with a particular focus on antifungal immunity.

PhD, FRS, FMedSci, FRSB, FAAM, FRSE, RSSAf, Director MRC Centre for Medical Mycology at the University of Exeter and Director of the AFGrica Unit at The University of Cape Town (UCT). PhD, Section Chief and Senior Investigator, Tuberculosis Research Section (TRS), National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH).ДЄreas of interest span the basic sciences of chemistry, biochemistry and microbiology, through to pharmacology and clinical medicine, in the areas of mycobacterial pathogenesis and TB drug discovery research. Adjunct membership is for researchers employed by other institutions who collaborate with IDM Members to the extent that some of their own staff and/or postgraduate students may work within the IDM for 3-year terms, which are renewable.